ArticleCancer immunology research2024

CD91 and Its Ligand gp96 Confer Cross-Priming Capabilities to Multiple APCs during Immune Responses to Nascent, Emerging Tumors.

Devanshi A Nayak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.